Evidence map›Paper›PMID 38260348›Full record

ArticlebioRxiv : the preprint server for biology2024

Direct interrogation of context-dependent GPCR activity with a universal biosensor platform.

Remi Janicot, Marcin Maziarz, Jong-Chan Park, Alex Luebbers, Elena Green, Jingyi Zhao, Clementine Philibert, Hao Zhang, Mathew D Layne, Joseph C Wu and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Remi JanicotDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Marcin MaziarzDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Jong-Chan ParkDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Alex LuebbersDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Elena GreenDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Jingyi ZhaoDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Clementine PhilibertDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Hao ZhangStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Mathew D LayneDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Joseph C WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Mikel Garcia-MarcosDepartment of Biochemistry & Cell Biology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.

Funding

Alternative Mechanisms of Signaling Via Trimeric G ProteinsR01NS117101 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Mikel Garcia-Marcos · 2020 to 2026
$3.4M
Non-canonical activation of heterotrimeric G protein signaling in vivoR01GM136132 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA-MARCOS, MIKEL · 2019 to 2022
$1.9M
Versatile and high-fidelity optical biosensor platforms for GPCR signalingR01GM147931 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA-MARCOS, MIKEL · 2023 to 2024
$850k
Molecular basis for GPCR signaling fine-tuning in neuronsF31NS115318 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LUEBBERS, ALEX · 2019 to 2022
$138k
NIGMS NIH HHS R01 GM136132NIGMS NIH HHS R01 GM147931NINDS NIH HHS F31 NS115318NINDS NIH HHS R01 NS117101
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are the largest family of druggable proteins in the human genome, but progress in understanding and targeting them is hindered by the lack of tools to reliably measure their nuanced behavior in physiologically-relevant contexts. Here, we developed a collection of compact ONE vector G-protein Optical (ONE-GO) biosensor constructs as a scalable platform that can be conveniently deployed to measure G-protein activation by virtually any GPCR with high fidelity even when expressed endogenously in primary cells. By characterizing dozens of GPCRs across many cell types like primary cardiovascular cells or neurons, we revealed new insights into the molecular basis for G-protein coupling selectivity of GPCRs, pharmacogenomic profiles of anti-psychotics on naturally-occurring GPCR variants, and G-protein subtype signaling bias by endogenous GPCRs depending on cell type or upon inducing disease-like states. In summary, this open-source platform makes the direct interrogation of context-dependent GPCR activity broadly accessible.

Identifiers

PMID38260348
PMCPMC10802303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.